An Open-label, Single-center Trial to Evaluate Systemic Exposure of Catechins From Commercially Available, Topically Applied Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2012
At a glance
- Drugs Green tea; Polyphenon E
- Indications Viral infections; Warts
- Focus Pharmacokinetics
- Sponsors MediGene Inc
- 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2011 New trial record